Detection of aberrant p16INK4A methylation in sera of patients with HCV-related liver diseases: An Egyptian study

Case Reports and Clinical Practice Review

Volumn 16, Issue 9, 2010, Pages 410-415

  Ahmed, Rasha ^a   Salama, Hosny ^a   Fouad, Ahmed ^a   Sabry, Dina ^a   AbdAlah, El Sayed ^a   Kamal, Manal ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Hepatocellular carcinoma; Liver cirrhosis; Methylation specific PCR; P16INK4A methylation

Indexed keywords

ALPHA FETOPROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER; VIRUS RNA;

ADULT; ARTICLE; BLOOD ANALYSIS; CHRONIC ACTIVE HEPATITIS; CONTROLLED STUDY; DISEASE ACTIVITY; DNA METHYLATION; EGYPT; ENZYME MECHANISM; FEMALE; GENETIC ASSOCIATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; VIRUS DETECTION; AGAR GEL ELECTROPHORESIS; BLOOD; CHRONIC HEPATITIS; GENETICS; LIVER DISEASE; LIVER TUMOR; METABOLISM; MIDDLE AGED; PHYSIOLOGY; VIROLOGY; CANCER RISK; HEPATITIS C;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; EGYPT; ELECTROPHORESIS, AGAR GEL; FEMALE; HEPACIVIRUS; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, VIRAL;

EID: 77956978819     PISSN: 15076164     EISSN: 16433742     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lehman EM, Wilson ML: Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat, 2009; 16(9): 650-658
2. Bièche I, Asselah T, Laurendeau I et al: Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection Virology, 2005; 332(1): 130-144
3. Anwar WA, Khaled HM, Amra HA et al: Changing pattern of hepatocellular carcinoma and its risk factors in Egypt: possibilities for prevention. Mutat Res, 2008; 659(1-2): 176-184
4. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutation in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res, 1994; 54: 4855-4878
5. Kondo Y, Kanai Y, Sakamoto M et al: Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis: A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology, 2000; 32: 970-979
6. Chaubert P, Gayer R, Zimmermann A et al: Germ-line mutations of the p16INK4 (MTS1) gene occur in a subset of patients with hepatocellular carcinoma. Hepatology, 1997; 25: 1376-1381
7. Merlo A, Herman JG, Mao L et al: 5'CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med, 1995; 1: 686-692
8. Razin A: CpG methylation, chromatin structure and gene silencing: a three-way connection. EMBO J, 1998; 17: 4905-4907
9. Kim JR, Kim SY, Kim MJ, Kim JH: Alterations of CDKN2 (MTS1/p16INK4A) gene in paraffin-embedded tumor tissues of human stomach, lung, cervix and liver cancers. Exp Mol Med, 1998; 30: 109-114
10. Kita R, Nishida N, Fukuda Y et al: Infrequent alterations of the p16INK4A gene in liver cancers. Int J Cancer, 1996; 67: 176-180
11. Lin YW, Chen CH, Huang GT et al: Infrequent mutations and no methylation of CDKN2A(p16/MTS1) and CDKN2B(p15/MTS2) in hepatocellular carcinoma in Taiwan. Eur J Cancer, 1998; 34: 1789-1795
12. Chaubert P, Gayer R, Zimmermann A et al: Germ-line mutations of the p16INK4 (MTS1) gene occur in a subset of patients with hepatocellular carcinoma. Hepatology, 1997; 25: 1376-1381
13. Liew CT, Li HM, Lo KW et al: High frequency of p16INKA4 gene alterations in hepatocellular carcinoma. Oncogene, 1999; 18: 789-795
14. Roncalli M, Bianchi P, Bruni B et al: Methylation frame work of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma. Hepatology, 2002; 36: 427-432
15. Kaneto H, Sasaki S, Yamamoto H et al: Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut, 2001; 48: 372-377
16. Wong IH, Lo YM, Zhang J et al: Detection of aberrant p16 methylation in the plasma and serum of liver cancers patients. Cancer Res, 1999; 59: 71-73
17. Shen L, Ahuja N, Shen Y et al: DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst, 2002; 94(10): 755-761
18. Herman JG, Graff JR, Myöhänen S et al: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 1996; 93(18): 9821-9826
19. Mikovits JA, Young HA, Vertino P et al: Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. J Korean Med Sci, 2004;19(1): 83-86
20. Chu HJ, Heo J, Seo S et al: Detection of Aberrant p16INK4A Methylation in Sera of Patients with Liver Cirrhosis and Hepatocellular Carcinoma. J Korean Med Sci, 2004; 19: 83-86
21. Nishida N, Nagasaka T, Nishimura T et al: Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatobiliary Malignancies Hepatology, 2008; 47(3): 908-918
22. Kurita S, Ohkoshi S, Yano M et al: Progression of hypermethylation of the p16(INK4A) gene from normal liver to nontumorous liver and hepatocellular carcinoma: an evaluation using quantitative PCR analysis. Dig Dis Sci, 2009; 54(1): 80-88
23. Wong IH, Lo YM, Lai PB, Johnson PJ: Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients. Clin Chem, 2000; 46: 1420-1422